Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Crea

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Prenatal Diagnosis|July 3, 2007
Workshop report on the extraction of foetal DNA from maternal plasmaTobias J Legler, Zhong Liu, Ariadni Mavrou, et al.
Clinical Epigenetics|February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Cancer Research|March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate CancerXinpei Ci, Jun Hao, Xin Dong, et al.
Molecular Oncology|January 27, 2016
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionFrancesco Crea, Luca Quagliata, Agnieszka Michael, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Prenatal Diagnosis|July 3, 2007
Workshop report on the extraction of foetal DNA from maternal plasmaTobias J Legler, Zhong Liu, Ariadni Mavrou, et al.
Clinical Epigenetics|February 16, 2016
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier-Luc Clermont, Francesco Crea, Yan Ting Chiang, et al.
Cancer Research|March 1, 2018
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate CancerXinpei Ci, Jun Hao, Xin Dong, et al.
Molecular Oncology|January 27, 2016
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionFrancesco Crea, Luca Quagliata, Agnieszka Michael, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE TransdifferentiationYu Wang, Hui Xue, Xiaohui Zhu, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.
Pageof 14